UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000020825 |
|---|---|
| Receipt number | R000023934 |
| Scientific Title | Establishment of a new home exercise therapy for the purpose of improvement of symptoms for Parkinson's disease patients |
| Date of disclosure of the study information | 2016/02/25 |
| Last modified on | 2026/02/13 10:34:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Establishment of a new home exercise therapy for the purpose of improvement of symptoms for Parkinson's disease patients
Acronym
Effect verification of aerobic exercise at home for Parkinson's disease patients
Scientific Title
Establishment of a new home exercise therapy for the purpose of improvement of symptoms for Parkinson's disease patients
Scientific Title:Acronym
Effect verification of aerobic exercise at home for Parkinson's disease patients
Region
| Japan |
Condition
Condition
Parkinson's disease
Classification by specialty
| Neurology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Verification of the effects of aerobic exercise at home for Parkinson's disease patients
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Finger taps test
(Four weeks after intervention)
Key secondary outcomes
gait
Muscle strength
Unified Parkinoson's Disease Rating Scale
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Behavior,custom |
Interventions/Control_1
4 weeks of aerobic exercise
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Hoehn and Yahr scale is within 3
Key exclusion criteria
Those with dementia
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Yoichi |
| Middle name | |
| Last name | Ohno |
Organization
Takasaki University of Health and Welfare
Division name
Department of Physical therapy, Faculty of Health care
Zip code
3700033
Address
501 nakaoruicho,takasaki city,gunma
TEL
0273521291
ohno@takasaki-u.ac.jp
Public contact
Name of contact person
| 1st name | Yoichi |
| Middle name | |
| Last name | Ohno |
Organization
Takasaki University of Health and Welfare
Division name
Department of Physical therapy, Faculty of Health care
Zip code
3700033
Address
501 nakaoruicho,takasaki city,gunma
TEL
0273521291
Homepage URL
ohno@takasaki-u.ac.jp
Sponsor or person
Institute
Takasaki University of Health and Welfare
Institute
Department
Personal name
Funding Source
Organization
Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Takasaki University of Health and Welfare
Address
501 nakaoruicho,takasaki city,gunma
Tel
0273521291
kuwabara@takasaki-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 02 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
25
Results
Outcome measures included walking speed, stride length, leg muscle strength, UPDRS3 score, and finger tapping parameters (maximum distance, total path length, and movement speed). Significant improvements were observed in walking speed (p < 0.05), UPDRS3 score (p < 0.01), and total path length (p < 0.01).
Results date posted
| 2026 | Year | 02 | Month | 13 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 02 | Month | 01 | Day |
Date of IRB
| 2015 | Year | 08 | Month | 11 | Day |
Anticipated trial start date
| 2016 | Year | 02 | Month | 26 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2026 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
| 2026 | Year | 03 | Month | 31 | Day |
Date analysis concluded
| 2026 | Year | 03 | Month | 31 | Day |
Other
Other related information
The report was published in International Journal of Physiotherapy, 2018; 5(1), and the project was concluded.
Management information
Registered date
| 2016 | Year | 02 | Month | 01 | Day |
Last modified on
| 2026 | Year | 02 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023934
